findmyKOL

Revekka Babayev

Basic profile

Stamford Hospital

ORCIDNone on fileNPI
RegionStamford, CT · NortheastSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Revekka Babayev is a Nephrology physician affiliated with Stamford Hospital. OpenAlex indexes 23 publications with 537 citations (h-index 11).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
23publications

Distinct works indexed by OpenAlex.

537citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

30 Commerce Rd
Stamford, CT 069024550

Telephone

203-324-7666

Registry record last updated 18 Dec 2015.

View the NPPES registry record

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Blood & clotting

    51.3%
    Erythropoiesis-stimulating Agent49.5%
    Darbepoetin alfa100%
    Part B, office-administered11 patients
    Solutions for parenteral nutrition1.1%
    Calcium Acetate100%
    Part D13 patients

    + 1 more class in this area

  • Cardiovascular

    31.2%
    Angiotensin receptor blocker (ARB)6.3%
    Losartan Potassium65%Valsartan17%Losartan-Hydrochlorothiazide8%Olmesartan-Hydrochlorothiazide5%Olmesartan Medoxomil5%
    Part D<11 patients
    Calcium channel blocker5.6%
    Amlodipine Besylate94%Nifedipine Er6%
    Part D<11 patients

    + 10 more classes in this area

  • Metabolism & gastrointestinal

    10.7%
    Vitamin D3 Analog3.7%
    Calcitriol100%
    Part D43 patients
    SGLT2 inhibitor2.9%
    Jardiance58%Farxiga42%
    Part D<11 patients

    + 4 more classes in this area

Where care is delivered (Part B)11.3% facility · 88.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”